Huons Meditech announced on the 5th that it participated in the 'Urological Association of Asia 2023,' Asia's largest urology conference, held in Dubai and the United Arab Emirates from the 28th of last month to the 1st.


Huons Meditech participated in the Asian Urological Association (UAA 2023) from the 28th of last month to the 1st of this month, showcasing the extracorporeal shock wave lithotripter ‘URO-EMXD’. Huons Meditech's booth set up at the conference. <br>[Photo by Huons Meditech]

Huons Meditech participated in the Asian Urological Association (UAA 2023) from the 28th of last month to the 1st of this month, showcasing the extracorporeal shock wave lithotripter ‘URO-EMXD’. Huons Meditech's booth set up at the conference.
[Photo by Huons Meditech]

View original image

The Urological Association of Asia is the annual academic conference of the Urological Association of Asia, where over 3,000 urologists from around the world gather.


At this exhibition, Huons Meditech showcased the premium extracorporeal shock wave lithotripter 'URO-EMXD,' which improves image quality and enhances procedural convenience, as well as 'IMPO88,' the first domestically proven effective treatment for erectile dysfunction.


The URO-EMXD is a magnetic-type extracorporeal shock wave lithotripter designed to easily detect urinary stones occurring inside the body. Equipped with a stone detection detector, it can quickly locate the position of stones, and by using the reflector moving function, it minimizes patient movement, enabling smooth procedures. Unlike previous products, it requires a shorter procedure time and offers the advantage of rapid recovery. The reflector is a shock wave generating device inside the lithotripter, and reflector moving can significantly reduce the degree of pain during the procedure for patients with stones.


Through this conference, Huons Meditech also introduced three types of lithotripters in the URO series, as well as the 'SDS-5000' acquired from MITECH in August, and the 'ASADAL M1' and 'MASON M1,' which have received FDA and CE certification in the United States.



A Huons Meditech representative said, "The URO-EMXD showcased at the exhibition is a product that simultaneously increases convenience for both the operator and the patient," adding, "We will continue to actively promote the excellence of medical devices developed with proprietary technology and strengthen our position as a global medical device specialist company."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing